[{"address1": "16 Abba Hillel Road", "city": "Ramat Gan", "zip": "5250608", "country": "Israel", "phone": "972 3 693 8448", "fax": "972 3 693 8447", "website": "https://galmedpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule for the treatment of non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study for HIV-associated lipodystrophy and non-alcoholic fatty liver disease. In addition, it develops products for cardiometabolic indications. The company has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with Virginia Commonwealth University to investigate the effect of adding Aramchol to prevent drug resistance to standard-of-care oncology agents in the treatment of hepatoma, cholangiocarcinoma, and colorectal cancer. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allen  Baharaff", "age": 59, "title": "Co-Founder, President, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1467116, "exercisedValue": 0, "unexercisedValue": 4940}, {"maxAge": 1, "name": "Mr. Doron  Cohen", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 252093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Nehemya", "age": 39, "title": "COO & Data Protection Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 294347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yohai  Stenzler CPA", "age": 41, "title": "Chief Accounting Officer", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 298107, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liat  Hayardeny MBA, Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tali  Gorfine", "age": 54, "title": "Medical Consultant", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 202763, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.98, "open": 1.95, "dayLow": 1.79, "dayHigh": 2.09, "regularMarketPreviousClose": 1.98, "regularMarketOpen": 1.95, "regularMarketDayLow": 1.79, "regularMarketDayHigh": 2.09, "payoutRatio": 0.0, "beta": 0.599, "forwardPE": -1.9320389, "volume": 401091, "regularMarketVolume": 401091, "averageVolume": 1808795, "averageVolume10days": 436160, "averageDailyVolume10Day": 436160, "bid": 1.95, "ask": 2.05, "bidSize": 1, "askSize": 1, "marketCap": 4493479, "fiftyTwoWeekLow": 1.15, "fiftyTwoWeekHigh": 23.8, "fiftyDayAverage": 1.7028, "twoHundredDayAverage": 2.354695, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -11235512, "profitMargins": 0.0, "floatShares": 2015115, "sharesOutstanding": 2258030, "sharesShort": 136924, "sharesShortPriorMonth": 66910, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.060599998, "heldPercentInsiders": 0.028959999, "heldPercentInstitutions": 0.02552, "shortRatio": 0.33, "shortPercentOfFloat": 0.0625, "impliedSharesOutstanding": 2258030, "bookValue": 7.474, "priceToBook": 0.26625636, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -7346000, "trailingEps": -6.6, "forwardEps": -1.03, "lastSplitFactor": "1:12", "lastSplitDate": 1724976000, "enterpriseToEbitda": 1.858, "52WeekChange": -0.47521096, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 1.99, "recommendationKey": "none", "totalCash": 15729000, "totalCashPerShare": 6.966, "ebitda": -6046250, "totalDebt": 0, "quickRatio": 8.952, "currentRatio": 9.019, "returnOnAssets": -0.23118, "returnOnEquity": -0.49580002, "freeCashflow": -3822375, "operatingCashflow": -5217000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1753487930, "regularMarketTime": 1753473601, "regularMarketChangePercent": 0.50505, "regularMarketPrice": 1.99, "exchange": "NCM", "messageBoardId": "finmb_114779940", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Galmed Pharmaceuticals Ltd.", "longName": "Galmed Pharmaceuticals Ltd.", "marketState": "CLOSED", "earningsTimestamp": 1747915216, "earningsTimestampStart": 1756238400, "earningsTimestampEnd": 1756756800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.6, "epsForward": -1.03, "fiftyDayAverageChange": 0.28719997, "fiftyDayAverageChangePercent": 0.16866335, "twoHundredDayAverageChange": -0.36469507, "twoHundredDayAverageChangePercent": -0.15487996, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "postMarketChangePercent": 2.47738, "postMarketPrice": 2.0393, "postMarketChange": 0.0493, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.79 - 2.09", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1808795, "fiftyTwoWeekLowChange": 0.84000003, "fiftyTwoWeekLowChangePercent": 0.73043483, "fiftyTwoWeekRange": "1.15 - 23.8", "fiftyTwoWeekHighChange": -21.81, "fiftyTwoWeekHighChangePercent": -0.91638654, "fiftyTwoWeekChangePercent": -47.521095, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394717400000, "displayName": "Galmed Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]